アルクス1転写因子は、眼筋形成を規定するために初期頭蓋中胚葉で作用する
Paul P R Iyyanar1, Nirpesh Adhikari1, Yu Lan1,2,3
1Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Abstract:
Loss of ALX1 gene function causes severe facial clefting and extreme microphthalmia. Previous studies suggest that ALX1 protein function is crucial for patterning the cranial neural crest cell (CNCC)-derived frontonasal mesenchyme, but how ALX1 regulates eye development is not well understood. Here, we show that Alx1 is transiently expressed in the embryonic cranial mesoderm and that Alx1-/- mice exhibit agenesis of extraocular muscles (EOMs) without affecting other muscles. We show that cranial mesoderm-specific Alx1 inactivation resulted in complete EOM agenesis accompanied by failure of activation of the core myogenic regulatory network specifically in, and increased apoptosis of, the EOM progenitor cells. Analysis of mice with temporally induced Alx1 inactivation demonstrated that EOM myogenesis requires Alx1 function before, but not after, formation of the EOM primordium. These data identify ALX1 as a unique and specific upstream regulator of EOM myogenesis, and provide new insights into pathogenic mechanisms underlying ALX1-type frontonasal dysplasia, as well as molecular mechanisms controlling cell fate specification in the early cranial mesoderm.
さらに関連する動画
12:54Real-time Analysis of Transcription Factor Binding, Transcription, Translation, and Turnover to Display Global Events During Cellular Activation
Published on: March 7, 2018
11:00Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Published on: December 16, 2016
関連する概念動画
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Transcription Elongation Factors
General Transcription Factors
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Master Transcription Regulators
